Cargando…
CAR-T cell therapy for hematological malignancies: History, status and promise
For many years, the methods of cancer treatment are usually surgery, chemotherapy and radiation therapy. Although these methods help to improve the condition, most tumors still have a poor prognosis. In recent years, immunotherapy has great potential in tumor treatment. Chimeric antigen receptor T-c...
Autores principales: | Wang, Chao, Wang, Jianpeng, Che, Shusheng, Zhao, Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658259/ https://www.ncbi.nlm.nih.gov/pubmed/38027932 http://dx.doi.org/10.1016/j.heliyon.2023.e21776 |
Ejemplares similares
-
CAR T-Cell Therapy in Hematological Malignancies
por: Haslauer, Theresa, et al.
Publicado: (2021) -
The journey of CAR-T therapy in hematological malignancies
por: Lu, Junru, et al.
Publicado: (2022) -
Current Progress in CAR-T Cell Therapy for Hematological Malignancies
por: Han, Donglei, et al.
Publicado: (2021) -
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
por: Wang, Hao, et al.
Publicado: (2019) -
The application of CAR-T cell therapy in hematological malignancies: advantages and challenges
por: Zhao, Zijun, et al.
Publicado: (2018)